We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+6.57%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$49.1B
AUM Growth
+$4.31B
Cap. Flow
+$1.72B
Cap. Flow %
3.51%
Top 10 Hldgs %
14.46%
Holding
3,114
New
67
Increased
2,155
Reduced
468
Closed
57

Sector Composition

Rank Sector Weight
1 Financials 14.36%
2 Healthcare 13.62%
3 Technology 13.02%
4 Industrials 11.1%
5 Energy 9.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RXII
2801
DELISTED
GALENA BIOPHARMA INC COM
RXII
$269K ﹤0.01%
119,000
MLR icon
2802
Miller Industries
MLR
$606M
$268K ﹤0.01%
15,800
CCXI
2803
DELISTED
ChemoCentryx, Inc.
CCXI
$268K ﹤0.01%
48,903
+2,037
+4% +$22K
VIRX
2804
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$267K ﹤0.01%
253
-24
-9% -$25.6K
CTIC
2805
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$267K ﹤0.01%
16,060
MHGC
2806
DELISTED
Morgans Hotel Group Co.
MHGC
$266K ﹤0.01%
38,000
CCBG icon
2807
Capital City Bank Group
CCBG
$881M
$265K ﹤0.01%
22,175
CYTK icon
2808
Cytokinetics
CYTK
$10.8B
$265K ﹤0.01%
+35,300
New +$379K
WNEB icon
2809
Western New England Bancorp
WNEB
$276M
$265K ﹤0.01%
37,600
HBIO icon
2810
Harvard Bioscience
HBIO
$28.8M
$264K ﹤0.01%
6,608
NBBC
2811
DELISTED
NEWBRIDGE BANCORP CLASS A COM STK (NC)
NBBC
$264K ﹤0.01%
36,000
INSY
2812
DELISTED
Insys Therapeutics, Inc.
INSY
$263K ﹤0.01%
+21,600
New +$177K
ARX
2813
DELISTED
Aeroflex Holding Corp (DE)
ARX
$263K ﹤0.01%
36,308
-3,169
-8% -$24K
RBCN
2814
DELISTED
Rubicon Technology, Inc.
RBCN
$262K ﹤0.01%
2,350
BRSS
2815
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
$262K ﹤0.01%
14,842
-1,174
-7% -$21.8K
DCOM icon
2816
Dime Commercial Bancshares
DCOM
$1.77B
$261K ﹤0.01%
11,800
VSEC icon
2817
VSE Corp
VSEC
$6.21B
$261K ﹤0.01%
11,000
ZGNX
2818
DELISTED
Zogenix, Inc.
ZGNX
$261K ﹤0.01%
16,713
PRSO icon
2819
Peraso
PRSO
$10.7M
$260K ﹤0.01%
8
LGTY
2820
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$260K ﹤0.01%
30,400
CCF
2821
DELISTED
Chase Corporation
CCF
$260K ﹤0.01%
+8,800
New +$247K
AHRT
2822
AH Realty Trust
AHRT
$503M
$259K ﹤0.01%
27,100
SCM icon
2823
Stellus Capital Investment Corp
SCM
$245M
$259K ﹤0.01%
17,274
USLM icon
2824
United States Lime & Minerals
USLM
$3.45B
$259K ﹤0.01%
21,995
+970
+5% +$11.3K
ENVE
2825
DELISTED
ENVENTIS CORP COM STK
ENVE
$258K ﹤0.01%
22,500

Similar funds

Charles Schwab's Q3 2013 Portfolio in Review

As of Q3 2013, Charles Schwab held 3,114 positions worth $49.1B, up 9.6% from $44.8B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $1.72B of net new capital in Q3 2013, opening 67 new positions and adding to 2,155 existing holdings. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Merck, an estimated $76M trimmed.

  • Charles Schwab's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,003,512 shares worth $136M.
  • Charles Schwab added most to Johnson & Johnson in Q3 2013, an estimated $125M increase.
  • Charles Schwab's biggest Q3 2013 reduction was Merck, cutting an estimated $76M.
  • Charles Schwab fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $47.2M.
  • Charles Schwab's ten largest holdings make up 14% of its $49.1B portfolio in Q3 2013.
  • Charles Schwab opened 67 new positions and closed 57 in Q3 2013.
  • Charles Schwab's portfolio value rose 9.6% quarter-over-quarter to $49.1B.

Based on Charles Schwab's 13F filing for Q3 2013, filed 14 Nov 2013.